Lykke Hinsch Gylvin: I Am Passionate. I Care Deeply About What I Do.

Lykke Hinsch Gylvin

Phase II Study of NALIRIFOX in Locally Advanced Pancreatic Carcinoma (LAPC) Shows Durable Disease Control and Improved Quality of Life

LAPC

Africa at the Center: World Cancer Leaders’ Summit 2027 Comes to Nairobi

World Cancer Leaders’ Summit 2027 Comes to Nairobi

Debra Patt: Visionary Leadership and Passion for Meaningful Change Shaping the Future of Medicine

Debra Patt

Florian Scotté: Best of MASCC in China

Florian Scotté, best of MASCC

Sir Ian Greer: Building Stronger Academic Ties Between Queen’s University Belfast and Kazakhstan

Sir Ian Greer

The Human Crisis in Cancer: Lancet Oncology Commission Calls for a More Humane Approach

The Human Crisis in Cancer: Lancet Oncology Commission Calls for a More Humane Approach

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

OncoCalendar

« All Events

12th ImmunoTherapy of Cancer Conference (ITOC12)

Mar 12, 2026 - Mar 14, 2026
ImmunoTherapy

The 12th ImmunoTherapy of Cancer Conference (ITOC12) is a European meeting scheduled to take place from March 12 – 14, 2026, in Munich, Germany. The conference provides a global platform focused on translational research in immuno-oncology, serving as a forum for the discussion of early clinical translation and its unique challenges. Organized by WMA GmbH in scientific cooperation with various international groups, including the ITOC Association, the Tumor Centre in Munich (TZM), and the German Cancer Consortium (DKTK), the main goal is to allow those dedicated to the immunotherapy of cancer to exchange their knowledge and latest findings to advance oncology drug development and delivery.

Details

Organizer

Venue